Literature DB >> 17473485

Evaluation of glucose tolerance, post-prandial hyperglycemia and hyperinsulinemia influencing the incidence of coronary heart disease.

Toshihiko Yamasa1, Satoshi Ikeda, Seiji Koga, Eisuke Kawahara, Takahiro Muroya, Hiroki Shinboku, Shigeru Kohno.   

Abstract

BACKGROUND: Recently, the frequency of patients who have glucose intolerance has been increasing in Japan. Glucose intolerance and insulin resistance/hyperinsulinemia are thought to influence the progression of atherosclerosis. The present study examined glucose tolerance, insulin resistance, post-prandial hyperglycemia/hyperinsulinemia and coronary risk factors by using 75 g oral glucose tolerance test (OGTT). PATIENTS AND METHODS: Coronary risk factors were examined and OGTT with measurement of plasma glucose and serum insulin was done to evaluate the glucose metabolism and insulin resistance in 263 patients who underwent coronary angiography; 202 subjects were diagnosed as having coronary heart disease (CHD) and 61 subjects were normal. We compared the two groups.
RESULTS: The rate of having diabetes was significantly high in the CHD group. From the result of OGTT, 22.3% of CHD patients had diabetes mellitus and 36.6% had impaired glucose tolerance, thus the total glucose intolerance rate was 57.7% in the CHD group. No significant difference was noted in the homeostatic model assessment-R (HOMA-R), but glucose and insulin at 2 hours after OGTT were all significantly high in the CHD group.
CONCLUSION: The rate of glucose intolerance and the levels of post-prandial glucose and insulin were high in the CHD group. We concluded that the post-prandial hyperglycemia and hyperinsulinemia influenced the incidence of CHD.

Entities:  

Mesh:

Year:  2007        PMID: 17473485     DOI: 10.2169/internalmedicine.46.6231

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  1 in total

1.  Association of different glucose traits with kidney function decline risk in a Chinese community-based population without chronic kidney disease.

Authors:  Xingang Wang; Fangfang Fan; Jia Jia; Xin Xu; Xianhui Qin; Bo Zheng; Haixia Li; Liguang Dong; Shuyu Wang; Jianping Li; Yong Huo; Jingtao Dou; Yan Zhang
Journal:  Ther Clin Risk Manag       Date:  2018-09-17       Impact factor: 2.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.